Complete Filing Data
Vir Biotechnology, Inc. reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents of $241.07 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Vir Biotechnology, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$438.0M | -$522.0M | -$615.1M | $515.8M | $528.6M | -$298.7M | -$174.7M | -$115.9M | -$69.9M |
| Revenues | $68.6M | $74.2M | $86.2M | $1.62B | $1.10B | $76.4M | $8.1M | $10.7M | $2.7M |
| Research And Development Expense | $456.0M | $506.5M | $579.7M | $474.6M | $448.0M | $302.4M | $148.5M | $100.2M | $62.5M |
| Other Nonoperating Income Expense | -$409.0K | -$2.2M | -$9.0M | $4.3M | -$9.4M | -$4.5M | -$5.1M | -$212.0K | $83.0K |
| Operating Income Loss | -$479.3M | -$587.2M | -$684.3M | $833.1M | $420.8M | -$297.0M | -$178.0M | -$118.7M | -$81.5M |
| Nonoperating Income Expense | $41.6M | $64.1M | $56.1M | -$78.8M | $129.1M | -$1.6M | -$3.5M | $2.3M | $721.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$437.8M | -$523.1M | -$628.2M | $754.3M | $549.8M | -$298.6M | -$174.5M | -$116.4M | -$80.8M |
| Comprehensive Income Net Of Tax | -$438.3M | -$522.9M | -$606.8M | $507.8M | $528.8M | -$299.3M | -$175.3M | -$115.9M | -$69.9M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$314.0K | $503.0K | $9.3M | -$7.5M | -$957.0K | -$50.0K | $149.0K | -$14.0K | |
| Income Tax Expense Benefit | $217.0K | -$1.1M | -$13.1M | $238.4M | $21.2M | $54.0K | $154.0K | -$480.0K | -$10.9M |
| Other Comprehensive Income Loss Reclassification Adjustment From AOCI Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax | $26.0K | $1.4M | $1.0M | $499.0K | -$1.1M | -$23.0K | $0.00 | ||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $8.3M | -$8.0M | $179.0K | -$677.0K | -$587.0K | -$14.0K | |||
| Selling General And Administrative Expense | $92.1M | $119.0M | $174.4M | $161.8M | $160.8M | $70.9M | $37.6M | ||
| Cost Of Revenue | $26.0K | $845.0K | $2.8M | $146.3M | $65.9M | $0.00 | $0.00 | ||
| Deferred Revenue Current | $64.9M | $15.5M | $98.2M | $6.5M | $6.2M | $8.8M | |||
| Operating Expenses | $373.3M | $186.1M | $129.4M | $84.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$163.1M | -$111.0M | -$121.0M | -$213.7M | -$138.4M | -$65.3M | -$163.4M | -$194.8M | -$141.0M | $175.3M | -$76.5M | $518.6M | $110.4M | $61.8M | -$168.9M | -$105.6M | -$84.6M | -$31.2M | -$77.2M | -$63.8M | -$48.3M | -$33.9M | -$28.7M | -$26.4M | -$33.5M | -$24.4M | -$31.6M | |
| Revenues | $240.0K | $1.2M | $3.0M | $2.4M | $3.1M | $56.4M | $2.6M | $3.8M | $63.0M | $374.6M | -$40.6M | $1.23B | $103.6M | $177.1M | $2.0M | $1.7M | $1.9M | $67.0M | $5.7M | $980.0K | $1.4M | $2.0M | $3.7M | $3.1M | $2.9M | $2.2M | $2.4M | |
| Research And Development Expense | $151.5M | $97.5M | $118.6M | $195.2M | $105.1M | $100.1M | $145.0M | $168.1M | $157.6M | $114.2M | $115.1M | $90.2M | $98.7M | $86.1M | $134.9M | $70.7M | $79.7M | $65.0M | $39.9M | $29.8M | $25.9M | $29.8M | ||||||
| Other Nonoperating Income Expense | -$228.0K | $226.0K | -$72.0K | -$893.0K | -$535.0K | -$287.0K | $882.0K | -$367.0K | -$8.0M | $27.0M | $691.0K | $2.7M | $64.0K | $752.0K | -$10.2M | $2.6M | -$2.9M | -$7.1M | -$2.7M | -$447.0K | -$145.0K | $178.0K | ||||||
| Operating Income Loss | -$173.4M | -$118.4M | -$139.5M | -$231.3M | -$158.6M | -$80.1M | -$186.7M | -$215.2M | -$143.4M | $195.0M | -$225.2M | $1.01B | -$53.4M | $61.0M | -$158.6M | -$87.6M | -$29.1M | -$71.9M | -$47.7M | -$35.8M | -$30.8M | -$34.3M | ||||||
| Nonoperating Income Expense | $10.5M | $7.6M | $18.6M | $17.8M | $18.7M | $15.1M | $20.1M | $17.6M | $183.0K | $22.8M | -$8.5M | -$91.9M | $164.1M | $849.0K | -$10.1M | $3.0M | -$2.1M | -$5.3M | -$647.0K | $1.9M | $2.1M | $890.0K | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$163.0M | -$110.8M | -$120.9M | -$213.5M | -$139.9M | -$65.0M | -$166.6M | -$197.6M | -$143.2M | $217.7M | -$233.7M | $921.9M | $110.8M | $61.9M | -$168.7M | -$84.6M | -$31.1M | -$77.2M | -$48.3M | -$33.9M | -$28.7M | -$33.5M | ||||||
| Comprehensive Income Net Of Tax | -$162.8M | -$111.2M | -$121.2M | -$209.7M | -$138.9M | -$66.9M | -$162.4M | -$194.5M | -$135.0M | $171.0M | -$79.2M | $514.9M | $110.5M | $61.8M | -$168.9M | -$84.8M | -$31.7M | -$76.4M | -$48.5M | -$33.8M | -$28.6M | -$33.5M | ||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $260.0K | -$295.0K | -$303.0K | $4.0M | -$491.0K | -$1.4M | $994.0K | $307.0K | $5.9M | -$4.3M | -$2.7M | -$3.7M | $13.0K | -$44.0K | -$40.0K | -$196.0K | -$549.0K | $844.0K | -$159.0K | $145.0K | $109.0K | -$25.0K | ||||||
| Income Tax Expense Benefit | $168.0K | $170.0K | $16.0K | $177.0K | -$1.5M | $276.0K | -$3.2M | -$2.8M | -$2.2M | $42.4M | -$157.2M | $403.3M | $334.0K | $53.0K | $196.0K | $22.0K | $46.0K | $16.0K | -$13.0K | $19.0K | ||||||||
| Other Comprehensive Income Loss Reclassification Adjustment From AOCI Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax | -$50.0K | -$49.0K | -$45.0K | -$10.0K | -$9.0K | $171.0K | -$9.0K | -$9.0K | -$9.0K | $9.0K | $9.0K | $10.0K | -$14.0K | -$14.0K | -$14.0K | -$6.0K | -$6.0K | -$5.0K | ||||||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $310.0K | -$246.0K | $4.0M | -$482.0K | -$1.6M | $1.0M | $316.0K | $5.9M | -$4.3M | -$2.7M | -$3.7M | $27.0K | -$30.0K | -$26.0K | -$190.0K | -$543.0K | $849.0K | -$159.0K | $145.0K | $109.0K | -$25.0K | |||||||
| Selling General And Administrative Expense | $22.2M | $22.3M | $23.9M | $25.7M | $30.3M | $36.3M | $40.9M | $45.5M | $46.8M | $43.2M | $41.6M | $38.3M | $50.5M | $28.8M | $25.7M | $18.9M | $16.4M | |||||||||||
| Cost Of Revenue | $11.0K | $0.00 | $50.0K | $52.0K | $59.0K | $38.0K | $22.0K | $1.9M | $22.3M | $27.9M | $90.1M | $7.8M | $1.1M | $0.00 | $0.00 | $0.00 | ||||||||||||
| Deferred Revenue Current | $0.00 | $10.1M | $11.9M | $12.6M | $15.2M | $16.7M | $14.7M | $15.3M | $15.7M | $17.2M | $22.9M | $113.2M | $113.7M | $96.2M | $44.7M | $262.9M | $5.6M | $7.3M | $5.0M | $8.8M | ||||||||
| Operating Expenses | $157.0M | $116.1M | $160.6M | $110.1M | $89.5M | $96.0M | $77.6M | $64.7M | $49.1M | $37.8M | $34.4M | $29.9M | $37.2M | $27.2M | $35.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $765.3M | $1.15B | $1.59B | $2.08B | $1.43B | $716.9M | $423.9M | -$179.2M | -$68.9M | -$8.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $241.1M | $318.7M | $261.3M | $868.0M | $363.4M | $451.5M | $122.8M | $59.4M | $188.9M | $14.1M |
| Restricted Cash And Cash Equivalents Noncurrent | $7.0M | $6.4M | $6.4M | $6.7M | $7.0M | $6.9M | $7.3M | $1.0M | $1.0M | |
| Cash And Cash Equivalents At Carrying Value | $232.2M | $222.9M | $241.6M | $848.6M | $347.8M | $436.6M | $109.3M | $47.6M | $187.9M | |
| Restricted Cash And Cash Equivalents At Carrying Value | $1.9M | $89.4M | $13.3M | $12.7M | $8.6M | $8.0M | $6.2M | $10.8M | ||
| Equity Securities Fv Ni Unrealized Gain Loss | $1.7M | -$5.5M | -$21.9M | -$111.1M | $138.0M | $0.00 | $0.00 | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$77.6M | $57.4M | -$606.7M | $504.6M | -$88.1M | $328.7M | $63.5M | -$129.6M | $174.8M | |
| Accretion Amortization Of Discounts And Premiums Investments | -$9.5M | -$5.4M | $8.7M | $8.9M | $244.0K | -$1.5M | $179.0K | $328.0K | ||
| Retained Earnings Accumulated Deficit | -$1.20B | -$759.8M | -$237.8M | $377.2M | -$138.6M | -$667.2M | -$368.5M | -$193.8M | ||
| Property Plant And Equipment Net | $55.6M | $63.2M | $96.0M | $105.6M | $42.8M | $17.9M | $16.3M | $12.3M | ||
| Prepaid Expense And Other Assets Current | $45.1M | $47.7M | $52.5M | $104.4M | $73.0M | $27.5M | $13.4M | $8.6M | ||
| Other Liabilities Noncurrent | $21.6M | $14.6M | $15.8M | $11.1M | $2.5M | $3.8M | $3.6M | $1.6M | ||
| Other Assets | $24.7M | $12.1M | $12.4M | $14.6M | $2.8M | $8.8M | $8.5M | $6.7M | ||
| Marketable Securities Current | $228.8M | $678.1M | $1.27B | $1.52B | $217.2M | $300.3M | $274.1M | $50.8M | ||
| Liabilities Current | $92.8M | $119.7M | $175.4M | $511.0M | $341.2M | $99.1M | $59.2M | $39.9M | ||
| Liabilities And Stockholders Equity | $1.00B | $1.40B | $1.92B | $2.80B | $1.95B | $918.8M | $512.1M | $191.6M | ||
| Liabilities | $237.5M | $248.4M | $328.8M | $724.1M | $522.4M | $201.9M | $88.1M | $61.6M | ||
| Intangible Assets Net Excluding Goodwill | $7.9M | $8.1M | $22.6M | $32.8M | $33.3M | $33.8M | $35.7M | $36.9M | ||
| Goodwill | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | ||
| Common Stock Value | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $13.0K | $11.0K | $1.0K | ||
| Business Combination Contingent Consideration Liability Noncurrent | $34.1M | $24.1M | $26.0M | $24.9M | $22.8M | $25.4M | $9.4M | $9.3M | ||
| Assets Current | $514.1M | $1.04B | $1.59B | $2.52B | $1.56B | $772.4M | $403.0M | $117.8M | ||
| Assets | $1.00B | $1.40B | $1.92B | $2.80B | $1.95B | $918.8M | $512.1M | $191.6M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.1M | -$1.7M | -$815.0K | -$9.1M | -$1.1M | -$1.3M | -$601.0K | -$14.0K | ||
| Accounts Payable Current | $9.8M | $5.1M | $6.3M | $6.4M | $6.5M | $5.1M | $5.9M | $6.5M | ||
| Noncash Lease Expense | $5.0M | $5.2M | $7.7M | $8.7M | $6.2M | $3.4M | ||||
| Accrued Liabilities And Other Liabilities | $83.0M | $98.5M | $104.2M | $489.1M | $236.5M | $76.9M | $26.5M | |||
| Other Operating Activities Cash Flow Statement | -$182.0K | $153.0K | -$383.0K | $697.0K | $23.0K | $345.0K | ||||
| Operating Lease Right Of Use Asset | $62.1M | $59.7M | $71.2M | $82.6M | $87.2M | $61.9M | ||||
| Operating Lease Liability Noncurrent | $89.1M | $90.1M | $111.7M | $123.8M | $133.6M | $66.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $796.1M | $947.5M | $1.04B | $1.15B | $1.24B | $1.43B | $1.55B | $1.59B | $1.68B | $1.81B | $1.97B | $2.08B | $2.15B | $1.95B | $2.00B | $876.3M | $737.3M | $651.0M | $812.4M | $563.8M | $380.3M | -$280.8M | -$237.0M | -$205.2M | -$154.0M | -$122.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $179.3M | $306.3M | $368.0M | $264.3M | $317.2M | $180.5M | $472.4M | $686.9M | $842.6M | $984.0M | $1.53B | $835.8M | $727.6M | $756.0M | $537.0M | $473.1M | $384.0M | $178.7M | $105.4M | $93.3M | $73.1M | $62.3M | ||||
| Restricted Cash And Cash Equivalents Noncurrent | $7.0M | $7.0M | $6.3M | $6.4M | $6.4M | $6.4M | $7.1M | $6.7M | $6.7M | $7.3M | $8.4M | $9.0M | $7.0M | $7.0M | $7.0M | $1.2M | $1.2M | $1.2M | $2.9M | $1.0M | $1.0M | $1.0M | ||||
| Cash And Cash Equivalents At Carrying Value | $170.1M | $211.1M | $273.6M | $168.4M | $296.9M | $160.7M | $452.1M | $666.9M | $824.9M | $963.7M | $1.51B | $812.4M | $714.5M | $742.0M | $521.4M | $462.5M | $371.8M | $168.4M | $93.7M | $80.7M | $64.7M | $47.7M | ||||
| Restricted Cash And Cash Equivalents At Carrying Value | $2.2M | $88.2M | $88.2M | $89.6M | $13.9M | $13.3M | $13.2M | $13.2M | $11.0M | $13.0M | $13.1M | $14.4M | $6.1M | $7.0M | $8.6M | $9.4M | $11.0M | $9.1M | $8.8M | $11.6M | $7.4M | $13.7M | ||||
| Equity Securities Fv Ni Unrealized Gain Loss | $1.3M | -$3.4M | $6.4M | $1.1M | $429.0K | -$5.9M | -$2.7M | -$5.1M | -$13.1M | -$13.6M | -$11.4M | -$95.0M | $164.1M | $0.00 | $0.00 | $0.00 | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $49.3M | -$80.8M | -$25.4M | $472.4M | $85.5M | $55.9M | $13.8M | |||||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | -$4.1M | -$238.0K | $9.4M | -$1.1M | -$409.0K | -$562.0K | $662.0K | |||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$1.15B | -$991.7M | -$880.7M | -$655.2M | -$441.5M | -$303.1M | -$121.9M | $41.6M | $236.3M | $478.8M | $303.5M | $380.0M | -$663.9M | $774.3M | -$836.1M | -$561.5M | -$476.9M | -$445.8M | -$304.7M | |||||||
| Property Plant And Equipment Net | $58.2M | $60.8M | $61.7M | $64.8M | $66.1M | $92.5M | $99.3M | $104.1M | $103.8M | $100.2M | $85.1M | $65.6M | $26.6M | $20.3M | $17.3M | $16.9M | $16.3M | $16.2M | $15.4M | |||||||
| Prepaid Expense And Other Assets Current | $37.0M | $41.5M | $42.4M | $43.1M | $40.7M | $50.0M | $59.4M | $85.7M | $97.6M | $54.2M | $72.4M | $69.9M | $27.8M | $29.2M | $26.5M | $13.6M | $15.4M | $12.8M | $8.7M | |||||||
| Other Liabilities Noncurrent | $13.3M | $13.0M | $14.8M | $13.9M | $13.9M | $14.2M | $13.1M | $12.1M | $8.2M | $7.2M | $7.6M | $7.7M | $3.8M | $3.9M | $3.8M | $3.0M | $3.0M | $2.9M | $3.0M | |||||||
| Other Assets | $16.0M | $13.2M | $5.9M | $11.6M | $13.3M | $12.5M | $14.7M | $16.9M | $16.6M | $6.2M | $2.8M | $3.0M | $2.3M | $7.9M | $7.1M | $9.9M | $8.8M | $7.7M | $13.7M | |||||||
| Marketable Securities Current | $327.8M | $387.6M | $517.4M | $740.6M | $849.8M | $985.1M | $1.23B | $1.17B | $1.41B | $1.36B | $654.1M | $399.8M | $55.6M | $84.1M | $211.6M | $364.1M | $180.6M | $187.2M | $226.5M | |||||||
| Liabilities Current | $75.2M | $105.0M | $137.3M | $117.2M | $96.4M | $94.1M | $165.1M | $225.6M | $485.3M | $308.2M | $477.9M | $702.4M | $233.7M | $146.0M | $361.1M | $77.0M | $54.9M | $56.4M | $44.3M | |||||||
| Liabilities And Stockholders Equity | $1.02B | $1.19B | $1.31B | $1.50B | $1.67B | $1.79B | $2.04B | $2.24B | $2.67B | $2.70B | $2.62B | $2.89B | $1.21B | $1.06B | $1.14B | $943.3M | $672.2M | $477.1M | $422.6M | |||||||
| Liabilities | $223.4M | $245.1M | $263.9M | $257.6M | $235.9M | $246.6M | $369.8M | $433.7M | $695.1M | $546.1M | $667.0M | $886.1M | $333.9M | $320.3M | $484.6M | $130.9M | $108.5M | $96.8M | $66.8M | |||||||
| Intangible Assets Net Excluding Goodwill | $7.9M | $8.0M | $8.1M | $19.3M | $18.9M | $22.5M | $25.5M | $25.6M | $32.6M | $32.9M | $33.0M | $33.2M | $33.4M | $33.6M | $33.7M | $33.9M | $35.1M | $35.4M | $36.0M | |||||||
| Goodwill | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | |||||||
| Common Stock Value | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $12.0K | $11.0K | $1.0K | |||||||
| Business Combination Contingent Consideration Liability Noncurrent | $34.2M | $33.6M | $23.6M | $33.2M | $30.6M | $27.6M | $24.3M | $24.9M | $23.7M | $30.7M | $28.5M | $18.9M | $20.7M | $42.7M | $46.0M | $31.7M | $30.7M | $14.0M | $3.3M | |||||||
| Assets Current | $545.7M | $735.7M | $932.2M | $1.05B | $1.21B | $1.21B | $1.77B | $1.95B | $2.36B | $2.41B | $2.29B | $2.57B | $1.07B | $862.3M | $993.1M | $849.6M | $578.8M | $377.5M | $337.7M | |||||||
| Assets | $1.02B | $1.19B | $1.31B | $1.50B | $1.67B | $1.79B | $2.04B | $2.24B | $2.67B | $2.70B | $2.62B | $2.89B | $1.21B | $1.06B | $1.14B | $943.3M | $672.2M | $477.1M | $422.6M | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.9M | -$2.2M | -$2.0M | $1.1M | -$2.9M | -$2.4M | -$1.9M | -$2.9M | -$3.2M | -$11.9M | -$7.6M | -$4.8M | -$1.3M | -$1.3M | -$1.3M | -$485.0K | -$295.0K | $248.0K | $81.0K | |||||||
| Accounts Payable Current | $6.8M | $12.2M | $3.7M | $7.3M | $4.4M | $7.1M | $3.6M | $12.4M | $12.1M | $2.7M | $10.6M | $11.0M | $4.2M | $11.0M | $3.7M | $6.8M | $4.4M | $18.8M | $5.8M | |||||||
| Noncash Lease Expense | $1.1M | $1.4M | $2.2M | $2.1M | $1.5M | $816.0K | ||||||||||||||||||||
| Accrued Liabilities And Other Liabilities | $68.4M | $82.7M | $104.1M | $94.7M | $75.3M | $72.3M | $146.1M | $197.6M | $455.9M | $282.6M | $354.1M | $577.7M | $64.8M | $64.1M | $70.1M | $44.3M | $38.6M | $21.9M | ||||||||
| Other Operating Activities Cash Flow Statement | $6.0K | -$176.0K | $206.0K | $209.0K | $19.0K | $5.0K | ||||||||||||||||||||
| Operating Lease Right Of Use Asset | $63.6M | $64.9M | $58.6M | $60.8M | $62.3M | $70.3M | $72.6M | $74.9M | $81.5M | $84.7M | $86.9M | $88.3M | $57.6M | $59.0M | $60.5M | $14.8M | $15.2M | $16.0M | ||||||||
| Operating Lease Liability Noncurrent | $91.2M | $93.4M | $88.2M | $93.4M | $95.0M | $109.2M | $114.1M | $117.8M | $121.5M | $126.9M | $130.2M | $132.8M | $68.6M | $68.9M | $66.6M | $12.1M | $12.8M | $13.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $11.7M | $14.6M | $19.5M | $6.8M | $5.3M | $4.4M | $3.3M | $1.6M | $255.0K |
| Share Based Compensation | $49.1M | $78.5M | $111.3M | $102.1M | $83.8M | $27.6M | $8.7M | $5.1M | $4.8M |
| Payments To Acquire Property Plant And Equipment | $4.8M | $7.3M | $21.6M | $68.0M | $21.8M | $6.5M | $8.9M | $8.2M | $2.7M |
| Net Cash Provided By Used In Operating Activities | -$391.8M | -$446.4M | -$778.8M | $1.66B | -$47.6M | -$190.9M | -$129.6M | -$94.1M | -$66.4M |
| Net Cash Provided By Used In Investing Activities | $310.4M | $499.4M | $164.6M | -$1.19B | -$140.8M | -$9.9M | -$256.2M | -$60.4M | -$30.0M |
| Net Cash Provided By Used In Financing Activities | $3.8M | $4.4M | $7.5M | $34.8M | $100.3M | $529.5M | $449.2M | $25.0M | $271.2M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.1M | -$4.4M | -$36.3M | $39.4M | $3.7M | $4.5M | $4.6M | $4.2M | $2.6M |
| Increase Decrease In Other Operating Assets | $12.6M | -$353.0K | -$2.2M | $11.8M | $1.5M | $1.1M | $1.9M | -$151.0K | $246.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$9.5M | -$64.0M | -$358.8M | -$15.5M | $58.5M | $46.6M | $10.2M | $7.2M | $4.8M |
| Increase Decrease In Accounts Payable | $5.0M | -$988.0K | $732.0K | $797.0K | -$171.0K | -$790.0K | $964.0K | $1.5M | $2.0M |
| Proceeds From Stock Options Exercised | $1.3M | $790.0K | $3.5M | $4.5M | $13.1M | $4.1M | $1.1M | $584.0K | |
| Payments To Acquire Investments | $886.3M | $1.24B | $2.02B | $1.48B | $420.2M | $403.8M | $643.9M | $123.1M | |
| Increase Decrease In Deferred Revenue | -$53.7M | -$2.3M | -$33.3M | $92.0M | -$7.0M | $3.5M | $7.9M | $888.0K | |
| Proceeds From Sale Maturity And Collections Of Investments | $1.20B | $1.74B | $2.20B | $351.5M | $301.2M | $400.3M | $396.7M | $72.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $2.9M | $4.5M | $4.5M | $4.6M | $5.6M | $1.6M | $1.5M | $1.4M | $1.4M | $1.3M | $1.3M | $1.1M | $1.1M | $1.0M | $900.0K | $800.0K | $706.0K | $400.0K |
| Share Based Compensation | $14.1M | $23.8M | $25.5M | $25.3M | $15.5M | $3.0M | $2.5M | |||||||||||
| Payments To Acquire Property Plant And Equipment | $1.6M | $1.9M | $6.9M | $15.8M | $667.0K | $1.3M | $3.5M | |||||||||||
| Net Cash Provided By Used In Operating Activities | -$78.1M | -$109.4M | -$125.8M | $550.1M | -$89.5M | -$48.4M | -$29.5M | |||||||||||
| Net Cash Provided By Used In Investing Activities | $126.8M | $28.4M | $98.1M | -$105.4M | $87.5M | $104.2M | -$274.2M | |||||||||||
| Net Cash Provided By Used In Financing Activities | $598.0K | $152.0K | $2.3M | $27.7M | $87.5M | $85.0K | $317.4M | |||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$5.1M | -$1.4M | -$9.5M | $247.0K | -$943.0K | -$549.0K | $367.0K | |||||||||||
| Increase Decrease In Other Operating Assets | -$6.2M | $86.0K | $2.0M | $227.0K | $63.0K | $125.0K | $188.0K | |||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $18.7M | -$30.0M | -$4.0M | $433.6M | -$18.8M | -$10.2M | -$2.0M | |||||||||||
| Increase Decrease In Accounts Payable | -$1.4M | $735.0K | $6.6M | $3.8M | -$1.3M | $12.9M | $1.2M | |||||||||||
| Proceeds From Stock Options Exercised | $598.0K | $221.0K | $2.3M | $484.0K | $2.4M | $143.0K | $67.0K | |||||||||||
| Payments To Acquire Investments | $173.7M | $562.9M | $384.5M | $89.6M | $5.0M | $40.5M | $322.8M | |||||||||||
| Increase Decrease In Deferred Revenue | -$713.0K | -$50.2M | $1.7M | $17.6M | $35.4M | -$3.2M | -$3.4M | |||||||||||
| Proceeds From Sale Maturity And Collections Of Investments | $301.9M | $592.7M | $489.5M | $0.00 | $93.2M | $145.8M | $52.1M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.16 | -$3.83 | -$4.59 | $3.83 | $3.96 | -$2.51 | -$5.76 | -$15.12 | -$32.45 |
| Weighted Average Number Of Shares Outstanding Basic | 138.5M | 136.2M | 134.1M | 132.6M | 129.9M | 119.2M | 30.3M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 138.5M | 136.2M | 134.1M | 134.8M | 133.4M | 119.2M | 30.3M | ||
| Earnings Per Share Basic | $-3.16 | $-3.83 | $-4.59 | $3.89 | $4.07 | $-2.51 | $-5.76 | ||
| Common Stock Shares Outstanding | 139.5M | 137.0M | 134.8M | 133.2M | 131.2M | 127.4M | 107.6M | 8.9M | |
| Common Stock Shares Issued | 139.5M | 137.0M | 134.8M | 133.2M | 131.2M | 127.4M | 107.6M | 8.9M | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 558.4M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.17 | -$0.80 | -$0.88 | -$1.56 | -$1.02 | -$0.48 | -$1.22 | -$1.45 | -$1.06 | $1.30 | -$0.58 | $3.85 | $0.82 | $0.46 | -$1.32 | -$0.67 | -$0.27 | -$0.71 | -$4.60 | -$3.64 | -$3.19 | -$3.05 | -$4.16 | -$3.35 | -$4.76 |
| Weighted Average Number Of Shares Outstanding Basic | 138.9M | 138.4M | 137.5M | 136.7M | 136.2M | 135.3M | 134.3M | 134.1M | 133.6M | 132.7M | 132.5M | 132.1M | 130.7M | 130.1M | 127.7M | 125.8M | 115.0M | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 138.9M | 138.4M | 137.5M | 136.7M | 136.2M | 135.3M | 134.3M | 134.1M | 133.6M | 135.0M | 132.5M | 134.5M | 133.9M | 133.8M | 127.7M | 125.8M | 115.0M | ||||||||
| Earnings Per Share Basic | $-1.17 | $-0.80 | $-0.88 | $-1.56 | $-1.02 | $-0.48 | $-1.22 | $-1.45 | $-1.06 | $1.32 | $-0.58 | $3.93 | $0.85 | $0.48 | $-1.32 | $-0.67 | $-0.27 | ||||||||
| Common Stock Shares Outstanding | 139.0M | 138.9M | 138.1M | 136.7M | 136.6M | 135.8M | 134.5M | 134.2M | 133.9M | 133.0M | 132.6M | 132.4M | 130.8M | 130.5M | 129.9M | 127.0M | 117.7M | 108.4M | 11.7M | ||||||
| Common Stock Shares Issued | 139.0M | 138.9M | 138.1M | 136.7M | 136.6M | 135.8M | 134.5M | 134.2M | 133.9M | 133.0M | 132.6M | 132.4M | 130.8M | 130.5M | 129.9M | 127.0M | 117.7M | 108.4M | 11.7M | ||||||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 558.4M | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.10 | $0.00 | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.10 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $49.1M | $78.5M | $111.3M | $102.1M | $83.8M | $27.6M | $8.7M | $5.1M | $4.8M |
| Stock Issued During Period Value Stock Options Exercised | $1.3M | $790.0K | $3.5M | $4.5M | $13.1M | $4.1M | $1.1M | $584.0K | |
| Costs And Expenses | $547.9M | $661.4M | $770.5M | $782.7M | $674.7M | $373.3M | $186.1M | ||
| Additional Paid In Capital | $1.97B | $1.91B | $1.83B | $1.71B | $1.57B | $1.39B | $793.1M | $14.7M | |
| Investment Income Net Amortization Of Discount And Premium | $87.0M | $28.1M | $439.0K | $2.8M | $8.5M | $2.5M | |||
| Change In Estimated Fair Value Of Contingent Consideration | $11.5M | $14.1M | $1.0M | $2.1M | $38.4M | $8.3M | $250.0K | $2.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $11.4M | $12.5M | $14.1M | $16.7M | $22.2M | $23.8M | $26.9M | $30.6M | $25.5M | $24.8M | $27.1M | $25.3M | $22.9M | $21.0M | $15.5M | $8.6M | $5.8M | $3.0M | $2.2M | $1.4M | $2.5M | $1.4M |
| Stock Issued During Period Value Stock Options Exercised | $101.0K | $649.0K | $598.0K | $71.0K | $410.0K | $220.0K | $343.0K | $742.0K | $2.3M | $2.0M | $1.1M | $484.0K | $3.7M | $3.6M | $2.4M | $1.2M | $2.2M | $143.0K | $364.0K | $635.0K | $67.0K | $311.0K |
| Costs And Expenses | $173.7M | $119.6M | $142.6M | $233.7M | $161.7M | $136.5M | $189.4M | $219.0M | $206.3M | $179.6M | $184.6M | $218.6M | $157.0M | $116.1M | $160.6M | |||||||
| Additional Paid In Capital | $1.95B | $1.94B | $1.93B | $1.89B | $1.88B | $1.85B | $1.80B | $1.77B | $1.74B | $1.68B | $1.66B | $1.63B | $1.54B | $1.51B | $1.49B | $1.37B | $1.04B | $825.8M | $23.9M | |||
| Investment Income Net Amortization Of Discount And Premium | $18.8M | $21.3M | $21.9M | $23.0M | $21.3M | $9.3M | $2.2M | $388.0K | $11.0K | $97.0K | $164.0K | $412.0K | $825.0K | $1.8M | ||||||||
| Change In Estimated Fair Value Of Contingent Consideration | $1.0M | $1.7M | -$1.2M | -$3.9M | $44.5M | $7.2M | $740.0K |
Most recent annual filing with the SEC: February 23, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.